新发全血细胞减少症患者的骨髓增生异常综合征
Myelodysplastic syndrome in a case of new-onset pancytopenia.
作者信息
Lancaster Ian, Patel Deep, Sethi Vikas, Connelly Weston, Namey Joseph
机构信息
HCA Healthcare/USF Morsani College of Medicine GME Programs Largo Medical Center Largo Florida USA.
出版信息
Clin Case Rep. 2022 Mar 3;10(3):e05533. doi: 10.1002/ccr3.5533. eCollection 2022 Mar.
Abstract
Myelodysplastic syndrome (MDS) is an infrequent cause of pancytopenia, which is a decrease in all three peripheral blood cell lines. We report the case of new-onset pancytopenia following administration of a COVID-19 vaccine and recurrent Zosyn use who was later found to have myelodysplastic syndrome.
摘要
骨髓增生异常综合征（MDS）是全血细胞减少的罕见病因，全血细胞减少是指外周血中三种血细胞系均减少。我们报告了一例在接种新冠疫苗及反复使用哌拉西林他唑巴坦后出现新发全血细胞减少的病例，该患者后来被诊断为骨髓增生异常综合征。
相似文献
1
Myelodysplastic syndrome in a case of new-onset pancytopenia.新发全血细胞减少症患者的骨髓增生异常综合征
Clin Case Rep. 2022 Mar 3;10(3):e05533. doi: 10.1002/ccr3.5533. eCollection 2022 Mar.
2
Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy.一名骨髓增生异常综合征患者的自身免疫性溶血性贫血：对5-氮杂胞苷治疗有反应。
J Oncol Pharm Pract. 2021 Oct;27(7):1775-1778. doi: 10.1177/1078155220987616. Epub 2021 Jan 14.
3
Significance of myelodysplastic syndrome-associated somatic variants in the evaluation of patients with pancytopenia and idiopathic cytopenias of undetermined significance.骨髓增生异常综合征相关体细胞变异在全血细胞减少和意义未明的特发性血细胞减少症患者评估中的意义。
Mod Pathol. 2016 Sep;29(9):996-1003. doi: 10.1038/modpathol.2016.100. Epub 2016 Jun 3.
4
Acute brucellosis with myelodysplastic syndrome presenting as pancytopenia and Fever of unknown origin.表现为全血细胞减少和不明原因发热的急性布氏杆菌病伴骨髓增生异常综合征。
Med Princ Pract. 2012;21(2):183-5. doi: 10.1159/000333698. Epub 2011 Dec 1.
5
6
[Successful treatment of myelodysplastic syndrome-associated autoinflammatory lymphedema with azacytidine].
Rinsho Ketsueki. 2019;60(12):1672-1675. doi: 10.11406/rinketsu.60.1672.
7
Apparent vaccine-thimerosal induced hypersensitivity, myelodysplastic syndrome and pancytopenia.
J Infect Dev Ctries. 2007 Dec 1;1(3):348-9.
8
New-Onset Monosomy 7-Induced Pancytopenia in a 66-Year-Old Woman.一名66岁女性新发7号染色体单体所致全血细胞减少症
Cureus. 2024 Jan 29;16(1):e53159. doi: 10.7759/cureus.53159. eCollection 2024 Jan.
9
Zosyn-Induced Rapid Thrombocytopenia in a Patient With End-Stage Renal Disease and HIV: A Case Report.终末期肾病合并艾滋病患者中哌拉西林/他唑巴坦诱发的快速血小板减少症：一例报告
Cureus. 2023 Dec 8;15(12):e50167. doi: 10.7759/cureus.50167. eCollection 2023 Dec.
10
Vitamin B(12)-responsive pancytopenia mimicking myelodysplastic syndrome.维生素 B(12)反应性全血细胞减少症，模仿骨髓增生异常综合征。
Acta Haematol. 2011;125(4):198-201. doi: 10.1159/000322941. Epub 2011 Jan 20.
引用本文的文献
1
Pancytopenia Concurrent With Metabolic Encephalopathy.全血细胞减少症并发代谢性脑病。
Cureus. 2024 Aug 27;16(8):e67963. doi: 10.7759/cureus.67963. eCollection 2024 Aug.
2
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2.血液转录组学分析为深入了解 SARS-CoV-2 变异体特异性免疫反应提供了线索。
Sci Rep. 2024 Feb 2;14(1):2808. doi: 10.1038/s41598-024-53117-w.
3
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2.血液转录组学分析为深入了解针对新冠病毒的变异特异性免疫反应提供了线索。
bioRxiv. 2023 Nov 6:2023.11.03.564190. doi: 10.1101/2023.11.03.564190.
4
Application of immunomodulatory therapy in a human brucellosis patient with pancytopenia: A case report.免疫调节疗法在一名全血细胞减少的人类布鲁氏菌病患者中的应用：病例报告。
Heliyon. 2023 Aug 5;9(8):e18907. doi: 10.1016/j.heliyon.2023.e18907. eCollection 2023 Aug.
本文引用的文献
1
A coronavirus disease-2019 induced pancytopenia.新型冠状病毒病-2019 导致的全血细胞减少症。
Am J Emerg Med. 2021 Sep;47:324.e1-324.e3. doi: 10.1016/j.ajem.2021.02.043. Epub 2021 Feb 24.
2
COVID-19-associated pancytopenia and typhlitis.COVID-19 相关全血细胞减少症和盲肠炎。
Am J Emerg Med. 2021 Jul;45:685.e1-685.e3. doi: 10.1016/j.ajem.2020.12.049. Epub 2021 Jan 4.
3
Etiology and clinico-hematological profile of pancytopenia: experience of a Mexican Tertiary Care Center and review of the literature.全血细胞减少症的病因及临床血液学特征：墨西哥一家三级护理中心的经验及文献综述
Hematology. 2019 Dec;24(1):399-404. doi: 10.1080/16078454.2019.1590961.
4
Approach to pancytopenia: Diagnostic algorithm for clinical hematologists.全血细胞减少症的处理方法：临床血液学家的诊断算法。
Blood Rev. 2018 Sep;32(5):361-367. doi: 10.1016/j.blre.2018.03.001. Epub 2018 Mar 5.
5
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.骨髓增生异常综合征，2.2017 年版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2017 Jan;15(1):60-87. doi: 10.6004/jnccn.2017.0007.
6
The diagnosis and management of the haematologic manifestations of lupus.狼疮血液学表现的诊断与治疗。
J Autoimmun. 2016 Nov;74:139-160. doi: 10.1016/j.jaut.2016.07.001. Epub 2016 Jul 25.
7
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
8
Evaluation and Management of Chronic Pancytopenia.慢性全血细胞减少症的评估与管理
Pediatr Rev. 2016 Mar;37(3):101-111; quiz 112-3. doi: 10.1542/pir.2014-0087.
9
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes.骨髓增生异常综合征中固有免疫和炎症信号传导的失调
Leukemia. 2015 Jul;29(7):1458-69. doi: 10.1038/leu.2015.69. Epub 2015 Mar 12.
10
The common causes leading to pancytopenia in patients presenting to tertiary care hospital.导致三级医院就诊患者全血细胞减少的常见原因。
Pak J Med Sci. 2013 Sep;29(5):1108-11. doi: 10.12669/pjms.295.3458.
Zotero 插件